Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNS020QD (Fentanyl 1-Day Patch) in Cancer Pain
NCT00641667Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by Janssen Pharmaceutical. Started Jan 2008; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00641667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641667.